Recent studies on lung cancer have shown that over 20% of lung cancer patients exhibit recurring changes in several SWI/SNF genes, some of which have a substantial correlation with a poor prognosis, indicating an essential function of SWI/SNF [132]. This evidence concerns the gene SMARCA1 and lung carcinoma.